Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment?
Details
Publication Year 2024-05-01,Volume 35,Issue #5,Page 409-411
Journal Title
Annals of Oncology
Publication Type
Editorial
Publisher
Elsevier
Department(s)
Laboratory Research
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-04-22 03:31:59
Last Modified: 2025-04-22 03:32:08
An error has occurred. This application may no longer respond until reloaded. Reload 🗙